scispace - formally typeset
R

Robert M. Kay

Researcher at Children's Hospital Los Angeles

Publications -  244
Citations -  9797

Robert M. Kay is an academic researcher from Children's Hospital Los Angeles. The author has contributed to research in topics: Cerebral palsy & Gait analysis. The author has an hindex of 53, co-authored 224 publications receiving 8829 citations. Previous affiliations of Robert M. Kay include University of Sheffield & Cleveland Clinic.

Papers
More filters
Journal ArticleDOI

Prevalence of specific gait abnormalities in children with cerebral palsy: influence of cerebral palsy subtype, age, and previous surgery.

TL;DR: The authors retrospectively reviewed a series of 492 consecutive cerebral palsy patients undergoing computerized motion analysis and found the likelihood of having stiff knee in swing, out-toeing, calcaneus deformity, and crouch increased with prior surgery.
Journal ArticleDOI

Operative treatment of supracondylar fractures of the humerus in children. The consequences of pin placement.

TL;DR: Fixation with only lateral pins is safe and effective for both Gartland type-2 and Gartlands type-3 supracondylar fractures of the humerus in children and prevents iatrogenic injury to the ulnar nerve.
Journal ArticleDOI

Cerebral palsy: clinical care and neurological rehabilitation

TL;DR: As the life expectancy of individuals with CP approaches that of the general population, therapies must be developed that address the needs of adults ageing with disability.
Journal ArticleDOI

Lateral-entry pin fixation in the management of supracondylar fractures in children

TL;DR: In this large, consecutive series without selection bias, the use of lateral-entry pins alone was effective for even the most unstable supracondylar humeral fractures.
Journal ArticleDOI

Clinical Behavior and A Contemporary Management Algorithm for Prepubertal Testis Tumors: A Summary of the Prepubertal Testis Tumor Registry

TL;DR: Initial excisional biopsy is recommended for all amenable prepubertal testis tumors, except those with an alpha-fetoprotein level that is clearly increased for patient age, including those with stage I yolk sac tumor.